Literature DB >> 1361231

Molecular mimicry of hepatitis B surface antigen by an anti-idiotype-derived synthetic peptide.

M W Pride1, H Shi, J M Anchin, D S Linthicum, P T LoVerde, A Thakur, Y Thanavala.   

Abstract

Monoclonal antibody 2F10 is an "internal-image" anti-idiotype (anti-id) antibody capable of mimicking the group-specific "a" determinant of human hepatitis B surface antigen (HBsAg). By mRNA sequencing and computer-assisted molecular modeling of monoclonal antibody 2F10, we identified a 15-amino acid region of the heavy-chain hypervariable region that has partial residue homology with sequences of the "a" determinant epitopes of HBsAg. We have established that a linear 15-mer peptide from a contiguous region on the anti-id antibody can (i) generate anti-HBsAg-specific antibodies when injected into mice, (ii) prime murine lymph node cells for in vitro HBsAg-specific T-cell proliferative responses, and (iii) stimulate in vitro human CD4+ T cells that were primed in vivo to HBsAg by natural infection with hepatitis B virus or vaccination with a commercially available HBsAg vaccine. Significantly, this peptide could also stimulate CD4+ T cells of human hepatitis B virus carriers. We conclude that a 15-mer peptide derived from the anti-id sequence can duplicate the B- and T-cell stimulatory activity of the intact anti-id antibody and the antigen that is mimicked, HBsAg.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1361231      PMCID: PMC50665          DOI: 10.1073/pnas.89.24.11900

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Toleration of amino acid substitutions within hepatitis B virus envelope protein epitopes established by peptide replacement set analysis. I. Region S(139-147).

Authors:  A R Neurath; M W Pride; N Strick; Y M Thanavala
Journal:  Pept Res       Date:  1990 May-Jun

2.  Sequences of the cell-attachment sites of reovirus type 3 and its anti-idiotypic/antireceptor antibody: modeling of their three-dimensional structures.

Authors:  W V Williams; H R Guy; D H Rubin; F Robey; J N Myers; T Kieber-Emmons; D B Weiner; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

3.  Immune response to a molecularly defined internal image idiotope.

Authors:  W V Williams; S D London; D B Weiner; S Wadsworth; J A Berzofsky; F Robey; D H Rubin; M I Greene
Journal:  J Immunol       Date:  1989-06-15       Impact factor: 5.422

4.  Structure of antibody hypervariable loops reproduced by a conformational search algorithm.

Authors:  R E Bruccoleri; E Haber; J Novotný
Journal:  Nature       Date:  1988-10-06       Impact factor: 49.962

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Synthetic idiotypes: the third hypervariable region of murine anti-dextran antibodies.

Authors:  S McMillan; M V Seiden; R A Houghten; B Clevinger; J M Davie; R A Lerner
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

7.  Towards a network theory of the immune system.

Authors:  N K Jerne
Journal:  Ann Immunol (Paris)       Date:  1974-01

Review 8.  Idiotypic vaccinations: consideration towards a practical application.

Authors:  K Eichmann; F Emmrich; S H Kaufmann
Journal:  Crit Rev Immunol       Date:  1987       Impact factor: 2.214

9.  Genetic alterations in the gene encoding the major HBsAg: DNA and immunological analysis of recurrent HBsAg derived from monoclonal antibody-treated liver transplant patients.

Authors:  G McMahon; P H Ehrlich; Z A Moustafa; L A McCarthy; D Dottavio; M D Tolpin; P I Nadler; L Ostberg
Journal:  Hepatology       Date:  1992-05       Impact factor: 17.425

10.  Immune response to synthetic peptide analogues of hepatitis B surface antigen specific for the a determinant.

Authors:  P K Bhatnagar; E Papas; H E Blum; D R Milich; D Nitecki; M J Karels; G N Vyas
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

View more
  13 in total

1.  Anti-idiotype antibody induced cellular immunity in mice transgenic for human carcinoembryonic antigen.

Authors:  Asim Saha; Sunil K Chatterjee; Kenneth A Foon; Malaya Bhattacharya-Chatterjee
Journal:  Immunology       Date:  2006-08       Impact factor: 7.397

2.  Immunogenicity of transgenic plant-derived hepatitis B surface antigen.

Authors:  Y Thanavala; Y F Yang; P Lyons; H S Mason; C Arntzen
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

3.  Delineation of the minimal hepatitis B surface antigen-specific B- and T-cell epitope contained within an anti-idiotype-derived pentadecapeptide.

Authors:  M Rajadhyaksha; Y Thanavala
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

4.  Induction of humoral and cell-mediated immune responses by hepatitis B virus epitope displayed on the virus-like particles of prawn nodavirus.

Authors:  Chean Yeah Yong; Swee Keong Yeap; Zee Hong Goh; Kok Lian Ho; Abdul Rahman Omar; Wen Siang Tan
Journal:  Appl Environ Microbiol       Date:  2014-11-21       Impact factor: 4.792

5.  Inadequate activation of the HBsAg-specific Th cells by APCs leads to hyporesponsiveness to HBsAg vaccine in B10.S mice.

Authors:  Xiaofei Li; Jing Xu; Zhihui Lv; Jing Wang; Shuhui Sun; Wei Zhu; Bin Wang; Rui He; Di Qu
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

6.  Mimicry of a neutralizing epitope of the major outer membrane protein of Chlamydia trachomatis by anti-idiotypic antibodies.

Authors:  L Brossay; A Villeneuve; G Paradis; L Coté; W Mourad; J Hébert
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

7.  Peptide mimicry of the meningococcal group C capsular polysaccharide.

Authors:  M A Westerink; P C Giardina; M A Apicella; T Kieber-Emmons
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

8.  Granulocyte-macrophage colony-stimulating factor mimicry and receptor interactions.

Authors:  J M Von Feldt; C Monfardini; T Kieber-Emmons; D Voet; D B Weiner; W V Williams
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

9.  Idiotypes as immunogens: facing the challenge of inducing strong therapeutic immune responses against the variable region of immunoglobulins.

Authors:  Alejandro López-Requena; Oscar R Burrone; Michela Cesco-Gaspere
Journal:  Front Oncol       Date:  2012-11-09       Impact factor: 6.244

10.  Anti-idiotypic antibodies: a new approach in prion research.

Authors:  Anja Colja Venturini; Maja Bresjanac; Tanja Vranac; Simon Koren; Mojca Narat; Mara Popović; Vladka Curin Serbec
Journal:  BMC Immunol       Date:  2009-03-19       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.